The Rare Cancer Research Foundation (RCRF) is a 501(c)3 dedicated to curing rare cancers through
New Therapeutic Targets in Alveolar Soft Part Sarcoma were revealed in a new study conducted
Below are links to eighteen publications describing clinical studies of ASPS with novel treatments as
We selected to highlight 3 studies that were presented this year at the ASCO conference:
Below are summaries of three clinical studies and one preclinical study on Alveolar Soft Part
Cancer Cell 26, 851-862, December 8,2014 The research from the group of Dr. Kevin Jones
Dr. Shamini Selvarajah presented a summary of her studies on Alveolar Soft Part Sarcoma at
Scientists from the group of Dr. Massimo Loda reported the results of an extensive study
Dr. Dina Lev, from the Cancer Biology and the Sarcoma Research Center at the University
A poster presented last month at the 2009 American Association for Cancer Research (AACR) Annual
Designed with ❤️ by Studio Luxmeo | Developed by Yoav Levavi